Anna Gardin: Incredible Initiative to Measure Clinician’s Own Lp(a) On The Spot at ESOC 2026
Anna Gardin, Neurology Resident at Stroke Unit, “G. Martino” University Hospital, shared on LinkedIn:
”At ESOC 2026, an incredible initiative gave clinicians the chance to measure their own Lp(a) on the spot.
As healthcare professionals, we talk to our patients about cardiovascular risk every day, but how often do we actually look at our own?
Fortunately, my Lp(a) are low (<15 nmol/L).
But this kind of screening is a powerful reminder: elevated Lp(a) can be the nudge we need to double down on the modifiable factors we can control.
And for those with high levels?
The good news is that the therapeutic landscape is evolving.
Novel Lp(a)-lowering agents are on the horizon, and the science is moving fast.
Lead by example. Know your risk.”
Stay updated with Hemostasis Today.
-
May 9, 2026, 14:10Grigoris Gerotziafas: The Evolving Landscape of Genetic Risk Assessment in VTE
-
May 9, 2026, 14:00Dorcas Gandhi: Telerehabilitation, Low-Cost Robotics in India and AVERT-DOSE Results at ESOC 2026
-
May 9, 2026, 13:50Khaled Musallam: Listening to Patients’ Needs and Challenges Remains the Foundation for a Better Care
-
May 9, 2026, 13:43Matías J Alet: Proud to Present the CAMINA Project on Argentina’s National Stroke Center Mapping at ESOC 2026
-
May 9, 2026, 13:28Maeva May: Stroke Association Is Proud to Support WHO Resolution on Global Stroke Advocacy
-
May 9, 2026, 11:44Somia Iqtadar։ A Meeting with the Scientist Who Helped Transform Anticoagulation
-
May 9, 2026, 11:33Awa Babington-Ashaye: WFH Congress Reflections on Access AI and Patient Care
-
May 9, 2026, 11:23Dirk Sibbing: Why CYP2C19 Genetics Matter in Clopidogrel Response
-
May 9, 2026, 11:19Postpartum Hemorrhage Risk as Remaining Challenge in Hemophilia Carriers – Journal of Thrombosis and Haemostasis